Showing results 1 to 60 of 98
|A Machine Learning Approach Using PET/CT-based Radiomics for Prediction of PD-L1 Expression in Non-small Cell Lung Cancer
|A Machine-Learning Approach Using PET-Based Radiomics to Predict the Histological Subtypes of Lung Cancer
|고영화, 안미선, 이수진
|A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806)
|A novel disintegrin salmosin inhibits tumor angiogenesis.
|A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer
|Aldehyde dehydrogenase is used by cancer cells for energy metabolism
|ALDH1 expression correlates with an epithelial-like phenotype and favorable prognosis in lung adenocarcinoma: a study based on immunohistochemistry and mRNA expression data
|고영화, 정준호, 한재호, 함석진
|An integrated single-cell transcriptomic dataset for non-small cell lung cancer
|Analysis of thromboembolic events in patients with non-small cell lung cancer who received adjuvant chemotherapy: single-center real-world data
|강석윤, 김태환, 신승수, 안미선, 이현우, 최용원, 최진혁
|Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea
|Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer
|Artificial intelligence–powered programmed death ligand 1 analyser reduces interobserver variation in tumour proportion score for non–small cell lung cancer with better prediction of immunotherapy response
|Assessment of textbook outcome after lobectomy for early-stage non-small cell lung cancer in a Korean institution: A retrospective study
|유우식, 정준호, 함석진
|Association between 18F-FDG uptake in PET/CT, Nrf2, and NQO1 expression and their prognostic significance in non-small cell lung cancer
|고영화, 이수진, 한재호
|Association between the CpG island methylator phenotype and its prognostic significance in primary pulmonary adenocarcinoma
|Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma
|Associations Between PET Textural Features and GLUT1 Expression, and the Prognostic Significance of Textural Features in Lung Adenocarcinoma
|Bilateral adrenal metastases revealed by F-18 FDG coincidence detection positron emission tomography in a patient with lung cancer.
|Cancer development in patients with COPD: a retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea
|박광주, 박범희, 박재범, 박주헌, 박지은, 박해심, 신승수, 황성철
|Changing trends in histologic types of lung cancer during the last decade (1981-1990) in Korea: a hospital-based study.
|Ciliated muconodular papillary tumor of the lung with cavitary change: A case report with 11-year preoperative follow-up
|고영화, 박경주, 선주성, 유슬기
|Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations
|Correlation between K-ras gene mutation and prognosis of patients with nonsmall cell lung carcinoma.
|Deep learning–radiomics integrated noninvasive detection of epidermal growth factor receptor mutations in non-small cell lung cancer patients
|김철호, 노진, 유슬기, 허재성
|DeepBTS: Prediction of Recurrence-free Survival of Non-small Cell Lung Cancer Using a Time-binned Deep Neural Network
|Diagnostic accuracy and safety of CT-guided percutaneous lung biopsy with a coaxial cutting needle for the diagnosis of lung cancer in patients with UIP pattern
|김다영, 박경주, 선주성, 유슬기
|Differential efficacy of tyrosine kinase inhibitors according to the types of EGFR mutations and agents in non-small cell lung cancer: a real-world study
|강석윤, 고영화, 김태환, 신승수, 안미선, 이현우, 최용원, 최진혁
|Differential expression and prognostic significance of GLUT1 according to histologic type of non-small-cell lung cancer and its association with volume-dependent parameters
|고영화, 박성용, 이수진
|Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors.
|Diffusion-Weighted Imaging of Brain Metastasis from Lung Cancer: Correlation of MRI Parameters with the Histologic Type and Gene Mutation Status
|Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer?
|DRG2 supports the growth of primary tumors and metastases of melanoma by enhancing VEGF-A expression
|Dummy Run of Quality Assurance Program before Prospective Study of Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases from Non-small Cell Lung Cancer: Korean Radiation Oncology Group (KROG) 17-06 Study
|Effect of formalin fixation and tumour size in small-sized non-small-cell lung cancer: a prospective, single-centre study
|Efficacy of concurrent chemoradiotherapy for patients with limited-disease small-cell lung cancer: a retrospective, nationwide, population-based cohort study
|EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non-Small Cell Lung Cancer Patients
|강석윤, 고영화, 박준성, 신승수, 이현우, 정성현, 최용원, 최진혁, 한재호
|Emphysema as a risk factor for the outcome of surgical resection of lung cancer.
|박경주, 박광주, 박주헌, 선주성, 신승수, 이규성, 이성수, 정우영, 최호, 황성철
|ESE1 suppresses the growth, invasion and migration of human NSCLC cells and tumor formation in vivo
|Evaluation of an adrenal mass in a patient with lung cancer by FDG coincidence positron emission tomography using a dual-head gamma camera.
|Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer.
|박광주, 신승수, 오윤정, 이기범, 한재호, 황성철
|Expression of PD-L1, cancer stem cell and epithelial–mesenchymal transition phenotype in non-small cell lung cancer
|고영화, 한재호, 함석진
|Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung.
|박광주, 박래웅, 박주헌, 신승수, 오윤정, 이규성, 최영화, 황성철
|False negative F-18 FDG PET/CT in nonsmall cell lung cancer bone metastases.
|윤석남, 윤준기, 조철우
|Fully covered, retrievable self-expanding metal stents (Niti-S) in palliation of malignant dysphagia: long-term results of a prospective study.
|김진홍, 신성재, 이광재, 이기명, 임선교
|Gene gun-mediated DNA vaccination induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs.
|GNAQ-Regulated ZO-1 and ZO-2 Act as Tumor Suppressors by Modulating EMT Potential and Tumor-Repressive Microenvironment in Lung Cancer
|HS-173 as a novel inducer of RIP3-dependent necroptosis in lung cancer
|Immune profiles according to EGFR mutant subtypes and correlation with PD-1/PD-L1 inhibitor therapies in lung adenocarcinoma
|고영화, 박범희, 이현우, 한재호, 함석진
|Indoor Radon and Lung Cancer: Estimation of Attributable Risk, Disease Burden, and Effects of Mitigation
|Indoor radon exposure increases tumor mutation burden in never-smoker patients with lung adenocarcinoma
|Interferon-induced transmembrane protein 1-mediated EGFR/SOX2 signaling axis is essential for progression of non-small cell lung cancer
|Interferon-γ-inducible chemokines as prognostic markers for lung cancer
|박광주, 박주헌, 박지은, 신승수, 이규성, 정우영, 정윤정
|Intratumoral heterogeneity as measured using the tumor-stroma ratio and PET texture analyses in females with lung adenocarcinomas differs from that of males with lung adenocarcinomas or squamous cell carcinomas
|고영화, 이다근, 이수진
|Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer?
|강석윤, 박준성, 안미선, 이순영, 이현우, 정성현, 최용원, 최진혁
|Is time-to-treatment associated with higher mortality in Korean elderly lung cancer patients?
|Lazertinib versus Gefitinib as First-Line Treatment for EGFR-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset
|Longitudinal monitoring by next-generation sequencing of plasma cell-free DNA in ALK rearranged NSCLC patients treated with ALK tyrosine kinase inhibitors
|Markedly Reduced Risk of Internal Malignancies in Patients With Vitiligo: A Nationwide Population-Based Cohort Study
|Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04.
|Neutrophilic eccrine hidradenitis in non-small cell lung cancer.